Atlas Venture

Atlas Venture, established in 1980, is a Cambridge, Massachusetts-based venture capital firm with a global presence. It manages over $2 billion in committed capital across multiple funds. The firm specializes in early-stage investing, focusing on life sciences and technology sectors. Atlas Venture creates and invests in biotech startups led by promising entrepreneurs, aiming to build scalable businesses and realize value. It typically invests $500,000 to $5 million in seed and early-stage rounds, with follow-on financing potentially reaching $10 to $20 million per company. Since 1995, Atlas Venture has been involved with over 350 companies, with 50 acquisitions and 40 IPOs.

Laura Alessio

Director of Portfolio operations

Peter Barrett

Partner, Legacy Funds

Bruce Booth

Partner

Ommer Chohan

CFO

Rajesh Devraj

Venture Partner

Maurizio Fazio

Principal

Jernej Godec Ph.D

Principal

David Grayzel

Partner

Julia Pian

Associate

Aimee Raleigh

Principal

Jason Rhodes

Partner

Steven Robinette

Venture Partner

Past deals in Maine

Phylogix

Series B in 2004
Phylogix Inc. is a biotechnology company focused on tissue protection and oncology. The company develops lectin-based drugs focused on tissue protection, oncology, and immunology. It also involves in the development of FRIL, an agent to protect patients from the toxic side-effects of chemotherapy. Phylogix Inc. is based in Scarborough, Maine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.